Facetten
Zugriff
Einrichtung
Medientyp
- Text 51
Karte
Erscheinungsjahr
Autor/in
- Jücker, Manfred
- Ehm, Patrick 8
- Nelson, Nina 8
- Ewald, Florian 7
- Grottke, Astrid 6
- alle zeigen
Sprache
51 Einträge gefunden
-
-
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo
- Schulte, Alexander
- Ewald, Florian
- Spyra, Melanie
- Smit, Daniel J
- Jiang, Wei
- Salamon, Johannes
- Jücker, Manfred
-
-
-
-
-
-
-
Akt isoform specific effects in ovarian cancer progression
- Linnerth-Petrik, Nicolle M
- Santry, Lisa A
- Moorehead, Roger
- Jücker, Manfred
- Wootton, Sarah K
- Petrik, Jim
-
Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells
- Holler, Marina
- Grottke, Astrid
- Mueck, Katharina
- Manes, Julia
- Jücker, Manfred
- Rodemann, H Peter
- Toulany, Mahmoud
-
-
Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
- Ewald, Florian
- Nörz, Dominik
- Grottke, Astrid
- Bach, Johanna
- Herzberger, Christiane
- Hofmann, Bianca T
- Nashan, Björn
-
ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts
- Kebenko, Maxim
- Drenckhan, Astrid
- Gros, Stephanie J
- Jücker, Manfred
- Grabinski, Nicole
- Ewald, Florian
- Grottke, Astrid
-
The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies
2015 - Forschungsinformationssystem des UKE - frei zugänglich -
AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice
- Grabinski, Nicole
- Möllmann, Katharina
- Milde-Langosch, Karin
- Müller, Volkmar
- Schumacher, Udo
- Brandt, Burkhard
- Pantel, Klaus
-
-
-
-
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
- Grabinski, Nicole
- Ewald, Florian
- Hofmann, Bianca T.
- Staufer, Katharina
- Schumacher, Udo
- Nashan, Björn
- Jücker, Manfred
-
Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
- Brauer, Helena
- Strauss, Julia
- Wegner, Wiebke
- Müller-Tidow, Carsten
- Horstmann, Martin
- Jücker, Manfred